Radioimmunoassay

The radioimmunoassay (RIA) is an innovative technique that harnesses the specificity of antibodies and the sensitivity of radioactivity to detect and quantify minute quantities of various substances in biological samples. Historically, it has been a primary tool for clinical laboratory analyses and has paved the way for significant advancements in fields such as endocrinology, virology, and pharmacology.

File:Radioimmunoassay process.png

Radioimmunoassay process

Principle of RIA

RIA is grounded in the principles of immunochemistry. It involves the competitive binding of a radiolabeled antigen (or antibody) and a non-radiolabeled antigen to a specific antibody (or antigen). The radiolabeled component serves as a tracer. Upon binding competition and separation of the bound from the free antigen, the amount of radioactivity is measured, which is inversely proportional to the concentration of the non-radiolabeled antigen in the sample<ref name="principle">Yalow, R. S., & Berson, S. A. (1960). Immunoassay of endogenous plasma insulin in man. The Journal of Clinical Investigation, 39(7), 1157–1175.</ref>.

Methodology

The fundamental steps of a RIA are:

• Preparation of the Radiolabeled Antigen: This involves attaching a radioactive isotope, typically iodine-125 or iodine-131, to the desired antigen.
• Incubation: The sample (which contains the unknown antigen) is mixed with both the radiolabeled antigen and the specific antibody. This initiates a competition between the radiolabeled and the non-radiolabeled antigen for the antibody binding sites.
• Separation: The mixture is then subjected to a separation process to distinguish the bound antigen-antibody complexes from the unbound antigens.
• Measurement: The radioactivity of the bound fraction or the free fraction is then measured using a gamma counter.

Applications of RIA

• Endocrinology: Measurement of various hormone levels, such as insulin, thyroid hormones, and reproductive hormones<ref name="endocrinology">Odell, W. D., & Wilber, J. F. (1971). Clinical uses of radioimmunoassay of protein and polypeptide hormones. New England Journal of Medicine, 284(4), 197–206.</ref>.
• Pharmacology: Detection and quantification of drugs and their metabolites in biological samples.
• Virology: Detection of viral antigens and antibodies, aiding in the diagnosis and management of viral infections<ref name="virology">Morgan, W. T. J. (1976). Radioimmunoassay in virology. Journal of Clinical Pathology, 29(10), 885–893.</ref>.

• Clinical Diagnostics: Measuring trace biomarkers indicative of disease conditions.

Advantages and Limitations

Advantages:

1. High Sensitivity: RIA can detect very low concentrations of antigens, sometimes down to picogram levels.
2. Specificity: Leveraging the specificity of the antigen-antibody reaction ensures accurate results.
3. Versatility: Can be adapted to measure a wide array of substances.

Limitations:

1. Radioactive Waste: Usage of radioactive materials necessitates careful handling and disposal protocols.
2. Short Shelf-life: Some radiolabels decay rapidly, shortening the usable lifespan of the assay reagents.

Technical Expertise: Requires specialized training and equipment.

Conclusion

The advent of RIA has revolutionized many sectors of biomedical science, offering a robust, sensitive, and specific method to detect and quantify various substances. Although newer non-radioactive immunoassays have emerged, RIA remains a foundational method, highlighting the intersection of immunology and radiobiology.

External links

• Radioimmunoassay at the US National Library of Medicine Medical Subject Headings (MeSH)

• Radioimmunoassay (RIA)

This article is a medical stub. You can help WikiMD by expanding it!
Most recent articles Ongoing trials	Wikipedia

References

<references />